
Haisco
Asia, Sichuan, China, Chengdu'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Haisco Pharmaceutical Group is a Chinese healthcare company focused on the research and development of therapeutic drugs.
Investor Profile
Haisco has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 100% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series D rounds (top funding stages).
- Majority of deals are located in Israel.
- Strong thematic focus on Health Care, Medical Device, Medical.
Stage Focus
- Series B (50%)
- Series D (50%)
Country Focus
- Israel (100%)
Industry Focus
- Health Care
- Medical Device
- Medical
- Biotechnology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Haisco frequently co-invest with?
Which angels does Haisco often collaborate with?
What are some of recent deals done by Haisco?
Find More Investors Like Haisco
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides







